Thomas Holst Laursen
With more than 25 years of experience, Thomas is one of the most experienced transaction lawyers in the market, having handled several of the largest and most complex transactions in the Danish market (including the Novonesis merger, SAS restructuring and acquisition, and Simcorp) and the market's recent IPOs (Netcompany and Gubra).
With transactions worth more than EUR 61 billion and 144 transactions (source: MergerMarket), Thomas is one of the highest ranked and recognised transaction lawyers in the market in both numbers and value. Thomas concentrates on M&A and capital markets transactions.
Thomas leads the market in all recognised rankings of Danish transactional lawyers (Chambers, Legal500, Lexology, etc..). According to research by Chambers Global: "Thomas Holst Laursen is the strongest commercial lawyer of his generation. He has the highest level of legal expertise combined with truly insightful, strategic and commercial insights." (2026)
Thomas mainly focuses on assisting corporate clients and foundations. Thomas' experience includes M&A mandates, cross-border M&A, take-private transactions, IPOs, ABBs, rights issues, and JV/merger transactions.
Thomas has a Master’s degree in Law from the University of Copenhagen and from Cambridge University.
Almost all the matters that Thomas is involved in require a multi-disciplinary team approach and project leadership. Clients continuously seek him and the team for their ability to provide a clear set of priorities, clear communication, and a deep commercial understanding of the client's needs.
Selected cases
- Advised Novozymes on the largest Danish merger with Chr. Hansen Holding
- Advised the Danish State on the restructuring of and sale and investment in SAS
- Advised Deutsche Börse on the public takeover offer to SimCorp's shareholders
- Advised Macquarie and the consortium on the public takeover offer to TDC shareholders
- Advised Zealand Pharma on licensing transaction to F Hoffmann-La Roche
- Advised Netcompany Group on acquisition of Skandinavisk Data Center (SDC)
- Advised the Danish State on the acquisition of Copenhagen Airports
- Advised on the equity financing in respect of DSV's acquisition of Schenker from Deutsche Bahn
- Advised Demant on sale of Oticon Medical's cochlear implant business to Cochlear
- Advised EQT Partners on the combination of Sivantos with Widex leading to WS Audiology
- Advised Zealand Pharma, Netcompany and Gubra on their IPOs
- Advised Ørsted on private placement of new shares to Goldman Sachs, etc.
- Advised the Danish State on the IPO of Ørsted
- Advised LEO Foundation and LEO Pharma on the partial sale to Nordic Capital
- Advised on the sale of Evosep, Santaris Pharma, Symphogen, and multiple other life science companies
- Advised founders on sales on 7N, Mono Solutions, Secure Device, and multiple other founder exits